Jan 17 , 2014 : Bharat Book Bureau presents the new report, on ”Europe Alzheimer’s Disease Drug Pipeline Analysis” which gives comprehensive insight on the various drugs being developed for the treatment of Alzheimer disease.
The incidence of Alzheimer’s disease has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been observed that close to 50% of dependency of aged people in Europe is attributed for by Alzheimer’s disease. The rapid growth in the prevalence of Alzheimer’s disease over the next few decades in Europe is expected to result in immense pressure on the social and health-care systems of the region. There is an urgent need for developing curative or disease-modifying therapies to offset the upcoming Alzheimer’s disease epidemic.
“Europe Alzheimer’s Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of Alzheimer disease. Research report covers all the ongoing drugs being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Alzheimer drug market based upon development process.
Following parameters for each drug profile in development phase are covered in “Europe Alzheimer’s Drug Pipeline Analysis” research report:
• Drug Profile Overview
• Alternate Names for Drug
• Active Indication
• Phase of Development
• Mechanism of Action
• Brand Name
• Patent Information
• Country for Clinical Trial
• Owner / Originator/ Licensee/Collaborator
• Administrative Route
• Drug Class
• ATC Codes
Europe Alzheimer’s Disease Drug Pipeline by Clinical Phase:
• Research: 19
• Preclinical: 49
Table of Contents:
1. Europe Alzheimer’s Disease Market Overview
2. Alzheimer’s Disease Drug Clinical Phase: Unknown
2.2 Alzheimer’s Disease Drug Profile in Clinical Phase
3. Alzheimer’s Disease Drug Clinical Phase: Research
3.2 Alzheimer’s Disease Drug Profile in Clinical Phase
4. Alzheimer’s Disease Drug Clinical Phase: Preclinical
4.2 Alzheimer’s Disease Drug Profile in Clinical Phase
5. Alzheimer’s Disease Drug Clinical Phase: Clinical
5.2 Alzheimer’s Disease Drug Profile in Clinical Phase
For more information kindly visit :
Related link :
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter: https://twitter.com/researchbook
Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : http://blog.bharatbook.com/
ListFree.org: Embedded data.